Treatment of Hyperhidrosis With Oxybutynin

• Status: Completed
• Trial end date: 2014-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Evaluation of the effectiveness of oxybutynin in hyperhidrosis

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Brest
• Collaborator: Ministry of Health, France
• Treatments: Mandelic Acids; Oxybutynin

Criteria

Inclusion Criteria:

• Age greater than 18 years

• Patient affiliated to social security or beneficiary of such a regime

• Patient able to consent

• Patient with hyperhidrosis, generalized or localized (palmar, plantar, axillary) and whose score HDSS (Hyperidrosis Disease Severity Scale) is greater than two.

Exclusion Criteria:

• Age less than 18 years

• Patient who can't be followed

• Patient participating in another clinical trial

• Pregnant

• Woman breastfeeding

• Hypersensitivity to oxybutynin or any of the excipients

• Risk of urinary retention related disorders uretroprostatiques

• Intestinal obstruction

• Toxic megacolon

• Intestinal atony

• Severe Ulcerative Colitis

• Myasthenia

• Closure glaucoma the anterior chamber angle or slightly deep